| Open Document File Size: 123,18 KBShare Result on Facebook
Company Merck and Co. / J Health-Syst Pharm / New England Journal / / Country United States / / Event FDA Phase / / IndustryTerm immune systems / combination product / / MedicalCondition cervical cancers / chickenpox / shingles / chicken pox / advanced renal failure / genital warts / fatal disease / Nephrogenic Systemic Fibrosis / birth defects / HPV disease / hypertension / disease / HPV / cervical cancer / varicella zoster / pain / permanent injury / renal failure / advanced kidney dysfunction / fibrosis / / MedicalTreatment medication errors / mechanical ventilation / dialysis / / Organization National Science Foundation / Institute for Safe Medication Practices / USP Safe Medication Use Expert Committee / FDA / / Position pharmacist / / Product Lotrel / Safe Medication / Prinzide / Omniscan / Tablet Splitting Splitting tablets / Zestril / Lotensin / If / Vasotec / enalaprilat / MultiHance / Capoten / Monopril / Univasc / Capozide / ramipril / pancuronium / lisinopril / Accupril / Prinivil / Accuretic / OptiMARK / USP Safe Medication / quinapril / Vaseretic / Magnevist / Aceon / ISMP Medication / Mavik / captopril / ProHance / Altace / trandolapril / hydrochlorothiazide / MRA / Recombinant Vaccine / / ProvinceOrState Oregon / / PublishedMedium Magnetic Resonance Imaging / the New England Journal of Medicine / / Technology MRI / Magnetic Resonance Imaging / dialysis / / URL http /
SocialTag |
FDA Patient Safety News: Show #54, August 2006